Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis.
Zelic M, Pontarelli F, Woodworth L, Zhu C, Mahan A, Ren Y, LaMorte M, Gruber R, Keane A, Loring P, Guo L, Xia TH, Zhang B, Orning P, Lien E, Degterev A, Hammond T, Ofengeim D. Zelic M, et al. Among authors: degterev a. Cell Rep. 2021 May 11;35(6):109112. doi: 10.1016/j.celrep.2021.109112. Cell Rep. 2021. PMID: 33979622 Free PMC article.
Targeting RIPK1,2,3 to combat inflammation.
Bullock AN, Degterev A. Bullock AN, et al. Among authors: degterev a. Oncotarget. 2015 Oct 27;6(33):34057-8. doi: 10.18632/oncotarget.6106. Oncotarget. 2015. PMID: 26472031 Free PMC article. No abstract available.
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.
Najjar M, Saleh D, Zelic M, Nogusa S, Shah S, Tai A, Finger JN, Polykratis A, Gough PJ, Bertin J, Whalen M, Pasparakis M, Balachandran S, Kelliher M, Poltorak A, Degterev A. Najjar M, et al. Among authors: degterev a. Immunity. 2016 Jul 19;45(1):46-59. doi: 10.1016/j.immuni.2016.06.007. Epub 2016 Jul 5. Immunity. 2016. PMID: 27396959 Free PMC article.
97 results